Biological

PHiD-CV vaccine clinical trials

studies test it: 34
open now: 0
in phase 3: 27
first study started: 2006

How studies write it

Studies that test it under each name

Studies by the year they started

33 studies that test it; most in 2009 (8)

Studies that test PHiD-CV vaccine, by start year
Year	Studies
2006	1
2007	6
2008	5
2009	8
2010	5
2011	2
2012	1
2013	2
2014	1
2015	1
2016	1

By phase

A phase 1/2 study counts in both.

Phase 1: 1
Phase 2: 3
Phase 3: 27
Phase 4: 4

What it is tested for

Each study’s main condition, where its own words name it.

Streptococcal Infections: 17
Pneumonia, Pneumococcal: 3
Respiratory Tract Infections: 1
Hepatitis B: 1
Pneumococcal Infections: 1
Rotavirus Infections: 1
Meningococcal Infections: 1

Who runs them

Industry 28 · Other 6

GlaxoSmithKline (28) · Nagasaki University (1) · Menzies School of Health Research (1) · PATH (1) · KEMRI-Wellcome Trust Collaborative Research Program (1) · Papua New Guinea Institute of Medical Research (1) · Public Health England (1)

Often tested with

Tested in the same studies.

Diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine (4) · 13-valent pneumococcal vaccine (3) · RIX4414 vaccine (2) · Meningococcal Vaccines (2) · Heptavalent Pneumococcal Conjugate Vaccine (1) · Hepatitis A Vaccines (1) · Chickenpox Vaccine (1) · GSK2202083A (1)

Studies

Open first, then newest update. How each study uses PHiD-CV vaccine is read from its arms, and is right about nine times in ten.

Testing it · 34

See all 34 studies that test PHiD-CV vaccine →

Given in every arm · 10 — PHiD-CV vaccine is usual care beside what is tested

As the comparator · 7 — what is tested is compared with PHiD-CV vaccine